检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:曾力楠[1,2] 易秋莎 张川[1,2] 黄超 李海龙 杨春松[1,2] 林茂[1,2,5] 黄亮 刘丹[1,2] 康德英[6] 刘关键[6] 刘巧兰[7] 赵荣生[8,9] 张俊华[10] 李幼平[6] 刘瀚旻[2,11] 王强 张伶俐 ZENG Linan;YI Qiusha;ZHANG Chuan;HUANG Chao;LI Hailong;YANG Chunsong;LIN Mao;HUANG Liang;LIU Dan;KANG Deying;LIU Guanjian;LIU Qiaolan;ZHAO Rongsheng;ZHANG Junhua;LI Youping;LIU Hanmin;WANG Qiang;ZHANG Lingli(Department of Pharmacy/Evidence-Based Pharmacy Centre,West China Second University Hospital,Sichuan University,Chengdu 610041,P.R.China;Key Laboratory of Birth Defects and Related Diseases of Women and Children,Ministry of Education,Chengdu 610041,P.R.China;West China School of Medicine,Sichuan University,Chengdu 610041,P.R.China;Medical Management Service Guidance Center,National Health Commission of the People’s Republic of China,Beijing 100044,P.R.China;West China School of Pharmacy,Sichuan University,Chengdu 610041 P.R.China;Chinese Evidence-Based Medicine Center,West China Hospital,Sichuan University,Chengdu 610041,P.R.China;West China School of Public Health,Sichuan University,Chengdu 610041,P.R.China;Department of Pharmacy,Peking University Third Hospital,Beijing 100191,P.R.China;Evidence-based Pharmacy Committee,Chinese Pharmaceutical Association,Beijing 100044,P.R.China;Centre for Evidence-Based Medicine,Tianjin University of TCM,Tianjin 301617,P.R.China;Department of Pediatrics,West China Second University Hospital,Sichuan University,Chengdu 610041,P.R.China)
机构地区:[1]四川大学华西第二医院药学部/循证药学中心,成都610041 [2]出生缺陷与相关妇儿疾病教育部重点实验室,成都610041 [3]四川大学华西临床医学院,成都610041 [4]国家卫生健康委医疗管理服务指导中心,北京100044 [5]四川大学华西药学院,成都610041 [6]四川大学华西医院中国循证医学中心,成都610041 [7]四川大学华西公共卫生学院,成都610041 [8]北京大学第三医院药剂科,北京100191 [9]中国药学会循证药学专委会,北京100044 [10]天津中医学大学循证医学中心,天津301617 [11]四川大学华西第二医院儿科,成都610041
出 处:《中国循证医学杂志》2020年第4期466-475,共10页Chinese Journal of Evidence-based Medicine
基 金:国家卫生健康委员会2018年委托课题(编号:医管办函〔2018〕44号)。
摘 要:目的建立由指南目标使用者担任评价者的指南临床适用性评价工具。方法课题组组建了多学科团队,通过系统评价现有指南临床适用性评价工具、两轮德尔菲法专家咨询及外审,循证建立指南临床适用性评价工具。结果指南临床适用性评价工具包括:①评价者基本信息12个条目;②指南临床适用性评价内容,包括可获得性、可读性、可接受性、可行性4个领域和总体评价共12个条目;③评分方案。结论本研究建立了由指南使用者任评价者的指南临床适用性评价工具,为循证评价指南临床适用性提供标准和方法。Objectives To establish a tool for evaluating clinical applicability of guidelines with the users of the guidelines as evaluators.Methods The research group formed a multidisciplinary team to establish an evidencebased tool for evaluating clinical applicability of guidelines through systematic evaluation and two rounds of Delphi expert consultation and external audit.Results The established tool consisted:evaluator basic information(12 items);clinical applicability evaluation(12 items,including availability,readability,acceptability,feasibility and overall evaluation);and scoring scheme.Conclusions This study has established a tool for evaluating clinical applicability of guidelines with the users of the guidelines as evaluators and provides criteria and methods for evaluating clinical applicability of guidelines.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.227.0.98